Novel conjugates <modified nucleoside – nanoparticle> to suppress the growth of superbugs
Close
Articolul precedent
Articolul urmator
735 3
Ultima descărcare din IBN:
2022-01-15 19:04
SM ISO690:2012
NEGRYA, S., EFREMENKOVA, O., ARTEMYEV, M., SIZOVA, S., OLEINIKOV, V., ALEXANDROVA, L.. Novel conjugates <modified nucleoside – nanoparticle> to suppress the growth of superbugs. In: NANO-2019: Limits of Nanoscience and Nanotechnologies, Ed. 2019, 24-27 septembrie 2019, Chişinău. Chișinău, Republica Moldova: 2019, p. 64.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
NANO-2019: Limits of Nanoscience and Nanotechnologies 2019
Conferința "SPINTECH Summer school “S/F Hybrid Structures for Spintronics”"
2019, Chişinău, Moldova, 24-27 septembrie 2019

Novel conjugates <modified nucleoside – nanoparticle> to suppress the growth of superbugs


Pag. 64-64

Negrya S.1, Efremenkova O.2, Artemyev M.34, Sizova S.3, Oleinikov V.3, Alexandrova L.1
 
1 Engelhardt Institute of Molecular Biology RAS,
2 Gause Institute of New Antibiotics,
3 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS,
4 Research Institute for Physical Chemical Problems, Belarusian State University
 
 
Disponibil în IBN: 27 ianuarie 2020


Rezumat

Nowadays practically all pathogenic bacteria and viruses have developed resistance to most clinically important medicinal preparations, hence, there is a need in new drugs acting on new targets and being active against superbugs - resistant strains of pathogens [1]. Recently we have synthesized 2’-deoxypyrimidine nucleoside derivatives bearing extended alkyloxymethyl or alkyl(1,2,3-triazol-1-yl)methyl substituents at С-5 position and demonstrated their effective bacteriostatic activity against two Mycobacterium tuberculosis strains [2] as well as against a set of Gram-positive bacteria [3]. However, the nucleosides with large hydrophobic fragments are insoluble in water, thus, limiting the biological investigations. To solve this problem, a linker group was introduced for coupling a nucleoside moiety to a nanoparticle. At the same time, we have developed fundamentally new nanostructures of the type “Plates” with both positive and negative surface charge [5] with uniquely high optical properties (narrow fluorescence peak, high extinction, high efficiency of two-photon excitation) and offered an efficient method for obtaining conjugates [nucleoside-nanoparticle]. To study the effect of nanostructures on bacterial cells were selected bacteria that differ in shape, structure and thickness of the cell wall. Herein we will present a new approach for transporting medicinal agents into bacterial cells to their targets, namely, the preparation of conjugates of biologically active nucleosides with nanoparticles.

Crossref XML Export

<?xml version='1.0' encoding='utf-8'?>
<doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'>
<head>
<doi_batch_id>ibn-92954</doi_batch_id>
<timestamp>1714499859</timestamp>
<depositor>
<depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name>
<email_address>idsi@asm.md</email_address>
</depositor>
</head>
<body>
<collection>
<collection_metadata>
<full_title>NANO-2019: Limits of Nanoscience and Nanotechnologies</full_title>
</collection_metadata>
<collection_issue>
<publication_date media_type='print'>
<year>2019</year>
</publication_date>
</collection_issue>
<collection_article publication_type='full_text'><titles>
<title>Novel conjugates &lt;modified nucleoside &ndash; nanoparticle&gt; to suppress the growth of superbugs</title>
</titles>
<contributors>
<person_name sequence='first' contributor_role='author'>
<given_name>S.</given_name>
<surname>Negrya</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>O.</given_name>
<surname>Efremenkova</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>M.</given_name>
<surname>Artemiev</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>S.</given_name>
<surname>Sizova</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>V.</given_name>
<surname>Oleinikov</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>L.</given_name>
<surname>Alexandrova</surname>
</person_name>
</contributors>
<publication_date media_type='print'>
<year>2019</year>
</publication_date>
<pages>
<first_page>64</first_page>
<last_page>64</last_page>
</pages>
</collection_article>
</collection>
</body>
</doi_batch>